USE OF 2-HYDROXY OR 2-ACETYLOXY-4-TRIFLUORO-METHYLBENZOIC ACID DERIVATIVES AS AN AGENT FOR THE TREATMENT AND PREVENTION OF MILD COGNITIVE IMPAIRMENT

The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for the treatment or prevention of mild cognitive impairment (MCI) in mammals, especially in human beings. Futhermore, the present invention also concerns the use of 2-hydroxy or 2-acety...

Full description

Saved in:
Bibliographic Details
Main Authors MUNOZ ORTI GENIS, GARCIA RAFANELL JULIAN, IZQUIERDO PULIDO JOSE IGNACIO, NAVAS RAMIREZ JOSE CARLOS
Format Patent
LanguageEnglish
Spanish
Published 16.07.2003
Edition5
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for the treatment or prevention of mild cognitive impairment (MCI) in mammals, especially in human beings. Futhermore, the present invention also concerns the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for delaying or preventing the conversion of MCI into dementia, especially Alzheimer's Disease. La presente invención se refiere al uso del ácido 2-hidroxi- o 2- acetiloxi-4-trifluorometilbenzoico, respectivamente, para el tratamiento o prevención del deterioro cognitivo ligero (DCL) en mamíferos, especialmente en seres humanos. Asimismo, la presente invención se refiere también al uso del ácido 2-hidroxi- ó 2- acetiloxi-4-trifluorometilbenzoico, respectivamente, para retrasar o prevenir la conversión de DCL a demencia, especialmente a enfermedad de Alzheimer.
Bibliography:Application Number: ES20010002725